
Chicago-based venture firm adds Indianapolis-based partner
Chicago-based M25, a venture firm that invests in early-stage Midwestern tech startups, has named local entrepreneur Brian Powers as its Indianapolis-based venture partner.
Chicago-based M25, a venture firm that invests in early-stage Midwestern tech startups, has named local entrepreneur Brian Powers as its Indianapolis-based venture partner.
The pre-clinical West Lafayette-based medical device startup is working to develop a new “microstructred” catheter to remove blood clots that cause strokes.
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
Four-year-old Novusterra Inc. is planning an initial public offering within 90 days and hopes to be approved to trade on the OTCQB Venture Market, often used by companies that are still developing.
Insignum AgTech and Grannus Therapeutics were among the five winners announced Wednesday.
Startups, small businesses and entrepreneurs who have an idea with commercialization potential can tap into a system of state funding and support through a research-focused grant program.
Primary Record allows families and other caregivers to organize and share medical information with one another and with doctors from their computer or phone.
Indiana is routinely touted for its positive business climate, but the state ranks 44th among states when it comes to creating new entrepreneurs, according to a recent study from the Indiana Chamber of Commerce.
Since he was tapped in 2022 to lead Indianapolis-based Elevate Ventures, Christopher Day has used his experience as an entrepreneur and investor to help the firm expand its growth investing.
Venture investing in tech firms was still sluggish in 2023 as compared to the peak activity of 2021, but a handful of Indiana-based tech companies and venture investors still got some big deals done this year.
The investment in Sudo Biosciences, a three-year-old Carmel biotech, is one of the largest in recent years for an Indiana-based science startup, a signal that investors are attracted by its work on a class of drugs to treat autoimmune and inflammatory diseases.
It’s been a brutal year for startups, with more companies struggling to raise money and hundreds shutting down altogether, according to new data.
Yourco’s co-founder and CEO, Brodie Meyer, said the company wasn’t necessarily looking to secure outside funding, but it found the right partner and decided that seed capital could help Yourco grow more quickly.
West Lafayette-based Neurava is one of 61 companies from around the world to showcase its medical technology as part of the 11th annual MedTech Innovator, billed as the largest accelerator of med tech companies.
Kyle Mohler founded Insignum Agtech with the idea of rearranging bits of corn’s DNA, then inserting them into popular field-corn hybrids.
Inventors and entrepreneurs who don’t have a track record face the biggest challenges, a panel of experts said Friday morning at IBJ’s Life Sciences Power Breakfast.
Conceptualized through venture studio High Alpha, Mandolin emerged during the pandemic as a successful concert livestreaming platform.
BiomEdit LLC was set up last year by Greenfield-based Elanco Animal Health and Boston-based Ginkgo Bioworks to make everything from food to therapeutics for animals. It’s already raised $36.5 million in venture capital for its work.
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
Recovery Force Health said it plans to use the new funding as growth capital to market its device to hospitals and introduce other products.